B-Secur raises $12m in new funding led by First Capital Ventures to expand in the US.
The financing round was led by First Capital Ventures with participation from existing investors.
B-Secur develops advanced ECG and EKG technology for consumer and medical devices. Its flagship HeartKey algorithms provide medical-grade monitoring capabilities for wearable technology.
B-Secur has secured $12m in new funding in a financing round led by Denver-based First Capital Ventures. Existing backers including Kernel Capital, Clarendon Fund Managers, and Wharton Asset Management also participated in the round.
The capital will be deployed to accelerate the company's commercial expansion across the United States within the consumer and medical sectors. The funding will additionally support the further development of its FDA-cleared HeartKey ECG technology as it integrates into consumer devices and remote patient monitoring systems.
Alongside the funding, B-Secur announced key executive appointments to bolster its American operations, including former Medtronic executive Dr David Steinhaus as Americas Advisor to the Board.
From the founder
"We are delighted to welcome First Capital Ventures as our latest and first U.S. investor alongside the continued commitment from our existing investor base."
Alan Foreman
CEO at B-Secur
Investor perspective
"We seek investment opportunities that make the world a better place and positively impact peoples’ lives,"
Gary Graham
Executive Managing Director, First Capital Ventures
Use of funds
- 01Expand into international markets
- 02Continue product development
Investors
Gary Graham
First Capital Ventures
Kernel Capital
Clarendon Fund Managers
Wharton Asset Management
Categories
About the company
B-Secur
B-Secur develops ECG technology and algorithms for consumer and medical devices.